Smart pumps may prevent dangerous drops in blood pressure during drug swaps

NCT ID NCT01127152

Completed Knowledge-focused Sponsor: Centre Hospitalier Departemental Vendee Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether using automatic pumps to switch syringes of noradrenalin (a drug that raises blood pressure) reduces the risk of hypotension compared to manual swaps. Fifty intensive care patients receiving noradrenalin were monitored. The goal was to see if automatic relays cut the number of blood pressure drops by half.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: noradrenalin
What this could lead to: If automatic relays reduce hypotension, this could lead to safer drug delivery in intensive care.
What could go wrong: This is a small, completed study with only 50 participants, so results may not apply broadly. The benefit may be small or not statistically significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypotensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPOTENSION

Contacts and locations

Locations

CHD Vendée

La Roche-sur-Yon, Vendée, 85925, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.